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Abstract.  We have developed two rat mAbs that 
recognize different subunits of the human fibroblast 
fibronectin receptor complex and have used them to 
probe the function of this cell surface heterodimer. 
mAb  13 recognizes the integrin class  1 beta polypep- 
tide and mAb  16 recognizes the fibronectin receptor 
alpha polypeptide. We tested these mAbs for their in- 
hibitory activities in cell adhesion,  spreading,  migra- 
tion, and matrix assembly assays using WI38 human 
lung fibroblasts, mAb  13 inhibited the initial  attach- 
ment as well as the spreading of WI38 cells on 
fibronectin and laminin  substrates but not on vitronec- 
tin.  Laminin-mediated  adhesion was particularly  sensi- 
tive to mAb  13.  In contrast,  mAb  16 inhibited initial 
cell attachment to fibronectin substrates but had no 
effect on attachment to either laminin  or vitronectin 
substrates.  When coated on plastic, both mAbs 
promoted WI38 cell spreading.  However, mAb  13 (but 
not mAb  16) inhibited the radial outgrowth of cells 
from an explant on fibronectin substrates,  mAb  16 
also did not inhibit the motility of individual fibro- 
blasts on fibronectin in low density culture and,  in 
fact,  substantially accelerated migration  rates.  In as- 
says of the assembly of an extracellular fibronectin 
matrix by WI38 fibroblasts, both mAbs produced sub- 
stantial  inhibition  in a concentration-dependent man- 
ner.  The inhibition of matrix assembly resulted from 
impaired retention of fibronectin on the cell surface. 
Treatment of cells with mAb  16 also resulted in a 
striking  redistribution of cell surface fibronectin recep- 
tors from a  streak-like pattern to a  relatively diffuse 
distribution.  Concomitant morphological changes in- 
cluded decreases in thick microfilament bundle forma- 
tion and reduced adhesive contacts of the streak-like 
and focal contact type. Our results indicate that the 
fibrol~last fibronectin receptor (a) functions in initial 
fibroblast attachment and in certain types of adhesive 
contact, but not in the later steps of cell spreading;  (b) 
is not required for fibroblast motility but instead 
retards migration;  and (c) is critically involved in 
fibronectin retention and matrix assembly. These 
findings suggest a central role for the fibronectin 
receptor in regulating cell adhesion and migration. 
T 
HE interaction  of cells with solid substrates  is impor- 
tant for their anchorage,  proliferation,  migration,  and 
differentiation.  Cells can attach,  spread, and migrate 
on a variety  of extracellular  glycoproteins including  fibro- 
nectin,  laminin,  vitronectin,  and collagen.  These interac- 
tions occur through  specific cell surface receptors.  Many of 
these cell adhesion receptors belong to a large superfamily 
of related  cell surface complexes called the integrins or the 
cytoadhesins  (for reviews see 3, 11, 26, 30, 33, 37, 52). The 
integrins  are noncovalent,  heterodimeric glycoprotein  com- 
plexes  that  consist of a  140,000-180,000-D  alpha  subunit 
and a  105,000-125,000-D  beta subunit.  The alpha  subunit 
often consists  of a  small,  transmembrane  polypeptide of 
20,000 D disulfide bonded to a larger, extracellular  poly- 
peptide (3, 6,  35, 48). 
The various integrin heterodimers have been divided into 
classes based on the different  beta polypeptides (33).  The 
class 1 integrins include the human T cell "very late antigen" 
(VLA) ~ heterodimers  (30,  31), the avian  140k fibronectin 
receptor complex (5, 32), the mammalian  fibronectin recep- 
tor (2, 9, 10, 49, 50, 60, 61), laminin receptors (25, 54, 58), 
and collagen receptors (31, 38, 55-57, 60, 61). Members of 
this family contain one of at least six unique,  but related,  al- 
pha subunits noncovalently associated with the common beta 
subunit. There are at least three different class 2 integrin het- 
erodimers  characteristically  present on  leukocytes.  There 
1.  Abbreviations  used in  this paper:  DPBS  +,  Dulbecco's phosphate-buf- 
fered saline with divalent cations; DPBS-, Dulbecco's phosphate-buffered 
saline without divalent cations; VLA, very late antigen. 
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class 3 beta subunit. Class 3 integrins include the platelet 
glycoprotein Ilb-HIa complex and the mammalian vitronec- 
tin receptor (17, 48). 
Both the alpha and beta subunits of the human fibronectin 
receptor have been cloned, and their sequences have been 
deduced (6, 7, 23). Both subunits have putative membrane- 
spanning  sequences,  small  carboxy-terminal  intracellular 
segments of 28 residues (alpha) or 47 residues (beta), and 
large  amino-terminal  extracellular  domains.  The  alpha 
subunits contain two to four putative calcium-binding se- 
quences. The beta subunits contain four cysteine-rich homol- 
ogous regions that presumably contain extensive intrachain 
disulfide bonding. Both subunits are glycosylated (2, 6, 7). 
mAbs have recently been produced against this receptor, 
which  is  thought  to  be  involved  in  cell  attachment  to 
fibronectin and which is expressed in tissue-specific patterns 
(10, 61). 
To elucidate the roles of this receptor in cell biological 
functions, we have used purified fibronectin receptor prepa- 
rations to develop mAbs that bind to the fibronectin receptor 
(also known as VLA 5).  Here, we describe two antibodies 
designated mAb 16 and mAb 13 which bind to the alpha and 
beta subunits, respectively, of the fibronectin receptor from 
cultured human fibroblasts. These antibodies define differ- 
ent functions of the fibronectin receptor in cell attachment 
or spreading,  cell migration, and extracellular matrix as- 
sembly. 
Materials and Methods 
Cell Culture 
WI38 fibroblasts (CCL 75; passages 18-24) were obtained from American 
Type Culture Collection (Rockville, MD). Human foreskin fibroblasts (pas- 
sages 6-12) were used for some early mAb screening experiments and were 
a generous gift from Dr. Steve Alexander (Bethesda Research Laboratories, 
Gaithersburg, MD). Both cell lines were cultured in DME supplemented 
with 10%  FCS (Hyelone Laboratories, Logan, UT),  1 mM glutamine, 1 
mM sodium pyruvate, 50 U/ml penicillin, and 50 #g/ml streptomycin (cul- 
tore medium). Hybridomas were routinely maintained as described (4). 
Purification of  Proteins and Immunological  Reagents 
Fibronectin and vitronectin were purified as described from fresh-frozen 
human plasma obtained from the Department of Transfusion Medicine (Na- 
tional Institutes of Health, Bethesda, MD) (1, 44, 64). The concentrations 
of fibronectin and vitronectin were determined by absorbance at 280 nm, as- 
suming extinction coefficients of 1.28 and 1.38 ml/mg, respectively, for a 
1-cm path length (19, 45). Laminin was obtained from Bethesda Research 
Laboratories. 
Sprngue-Dawley rats were immunized with fibronectin receptor purified 
from human placenta as described previously (47, 49, 50, 51). Hybridomas 
producing anti-fibronectin receptor mAbs were produced by the fusion of 
Y3 rat myeloma cells with spleen cells as described (24). Clones were first 
screened for those antibodies that recognized cell surface antigens in in- 
direct immunofiuorescenee staining of cultured human foreskin fibroblasts. 
The second and third screens were for those antibodies that recognized inte- 
grin polypeptides in immunoblots of human placenta homogenates or that 
could immunopreeipitate radioactive integrin polypeptides from lysates of 
human fibroblasts grown in the presence of 50 #Ci/ml  [35S]methionine. 
Useful clones were then subcloned twice by the method of limiting dilution. 
The mAbs were isotyped using a  commercially available  kit  (ICN  Im- 
munobiologicals, Irvine, CA). 
mAbs were purified from hybridoma-conditioned serum-free medium as 
described (4,  13).  Fab fragments of mAbs were obtained by incubating 
purified IgG with immobilized papain (Pierce Chemical Co., Rockford, IL) 
for 5  h  at 3"/*C following the manufacturer's instructions. The digestion 
products were examined by SDS-PAGE and were found to be free of intact 
IgG heavy chain, mAbs and Fab fragments were concentrated by vacuum 
dialysis  and  dialyzed against  Dulbecco's PBS  without  divalent cations 
(DPBS-). Polyclonal anti-human placental fibronectin receptor antibodies 
have been characterized previously (51). 
Assays  for Cell  Attachment and Cell Spreading 
Substrates for cell attachment and cell spreading assays were prepared as 
described (5, 63) using fibronectin, laminin, or vitroneetin at the concentra- 
tions indicated in the figure legends. The prepared substrates were covered 
with 100 #1 of serum-free DME which was removed  just before use. All sub- 
sequent  steps  of  both  assays  were  performed  at  37°C  with  reagents 
prewarmed to 37°C unless otherwise noted. 
Cell attachment was assayed by a modification of  the procedure of Nagata 
et  al.  (46).  WI38  fibroblasts  were  labeled  overnight  with  4  #Ci/ml 
[3H]thymidine  (21  Ci/mmol;  American  Radiolabeled  Chemicals,  St. 
Louis, MO) followed by a 2-h chase to deplete unincorporated label. The 
cells were washed with calcium- and magnesium-free Hanks' balanced salt 
solution and incubated in 0.25 % trypsin (Gibco Laboratories, Grand Island, 
NY) in calcium- and magnesium-free Hanks' balanced salt solution for 2 
min. The cells were then dislodged by shaking, suspended in 5 ml of regular 
culture  medium,  centrifuged,  resuspended  in  5  ml  of regular  culture 
medium, allowed to recover from the trypsinization for 20 min at 37°C, and 
counted. The cells were then centrifuged and resuspended in serum-free 
DME at a concentration of 2  ×  105 cells/ml. Aliquots (50 #1) of cells were 
mixed with 50-ul aliquots of various concentrations of antibodies in serum- 
free DME, added to substrates prepared with adhesion proteins, and in- 
cubated for 30 rain at 37°C in a 95% air, 5% CO2, humidified atmosphere. 
Unbound cells were removed by gentle aspiration.  The wells were then 
gently washed twice with serum-free DME by swirling at 150 rpm for 30 s. 
Bound cells were solubilized in 150 #i 2 % SDS in 0.01 N NaOH and quanti- 
tated by liquid scintillation spectrometry. Three 10-#1 aliquots of the origi- 
nal cell suspension were mixed with 150 #1 of 2% SDS, 0.01 N NaOH and 
counted to determine the amount of radioactivity added to each well. 
Cell spreading assays were performed essentially as described (5) with 
the following modifications. Subconfluent WI38 fibroblasts were prepared 
as described for the cell attachment assays, but not radiolabeled. Cells were 
suspended in serum-free DME and allowed to spread on substrates prepared 
with adhesion proteins for 1 h at 37°C in a  CO2 incubator before being 
fixed and quantitated as described (28, 29). 
Background levels in both the cell attachment and the cell spreading as- 
says were determined by adding cells to wells that had not been exposed to 
adhesion proteins before being blocked with heat-denatured BSA. In addi- 
tional control experiments, either purified nonimmune rat  IgG  (Calbio- 
chem-Behring Corp., La Jolla, CA) or a class-matched, control rat mAb 
was used. Neither control antibody had significant inhibitory effects at con- 
centrations equal to or greater than those used for mAbs 13 and 16. It should 
also be noted that wide ranges of antibody concentrations were chosen to 
rule out artifacts such as possible prozone effects. 
Cell Migration Assays 
Cell migration was quantitated by determining the extent of outward cell 
migration from an agarose droplet using a modification of the methods of 
Varani ct al. (59). Cells were harvested and resuspended at a concentration 
of 3.3  x  107 cells/ml in growth medium prepared with bicarbonate-free 
DME buffered with 25 mM Hepes, pH 7.4 (Gibco Laboratories). After ad- 
justing to 0.2%  agarose using a  stock of 2%  low melting point agarose 
(Bethesda Research Laboratories) maintained at  ~38°C,  the cells were 
plated in 1-#1 droplets on Immulon I (Dynatech Laboratories, Chantilly, VA) 
96-well plastic substrates precoated with 5 #g/ml human plasma fibronectin. 
After the agarose was gelled by incubation at 40C for 5 rain, regular growth 
medium containing the indicated quantities of mAb was added with care to 
avoid detachment of the droplets. Cells were cultured in a CO2 incubator 
for 2 d and then fixed with 4% formaldehyde. After rinsing, cultures were 
stained with 1% crystal violet in 95% ethanol, destained in water, and air 
dried. Each well was photographed by transmitted light using a dissecting 
microscope. Total areas of  cell outgrowth were digitized using a Sigma-Scan 
measurement system to measure the outer perimeter of  the sheets of radially 
migrating cells (Jandel Scientific, Corte Madera, CA). Photographs of zero- 
time control agarose droplets were also digitized, and these areas were sub- 
tracted from total outgrowth to calculate net areas of outgrowth. 
The migration of individual cells was quantitated by time-lapse video mi- 
croseopy. Plastic 35-ram Petri dishes (Falcon Labware, Oxnard, CA) were 
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denatured BSA as described (63).  WI38 fibroblasts were plated in bicar- 
bonate-free DIME containing 10% heat-inactivated  FCS and 25 mM Hepes 
at 104 cells/mi: The dishes were sealed and placed on the stage of an in- 
verted microscope (Carl Zeiss, Inc., Thornwood, NY) enclosed within a 
chamber maintained at 37 + 0.2°C. Cells were visualized with a video cam- 
era (2000; RCA, Lancaster,  PA) connected to a time-lapse video cassette 
recorder (AG 6010; Panasonic, Secaucus, N J). Migration of cells was traced 
at 1- or 3-h intervals over a 15-h period starting 6 h after plating. Cell paths 
marked at  l-h intervals  were traced for illustrations.  Alternatively,  indi- 
vidual time segments were digitized from 3-h time points on the tracings. 
At least 40 time segments  were digitized  for each condition. 
Assays for Fibronectin Matrix Accumulation 
and Assembly 
WI38 fibroblasts  were plated at 3  x  105 cells/ml in 8-well chambers on a 
glass  substrate (Lab-Tek;  Miles  Scientific  Div.,  Naperville,  IL)  in 0.4 
ml/well regular culture medium containing the indicated concentrations of 
mAb, control rat IgG, or class-matched control rat mAb. After 24 h of cul- 
ture, the medium was removed, and the monolayers were rinsed and fixed with 
4%  formaldehyde with 5%  sucrose (to suppress blebbing) in Dulbecco's 
PBS with divalent cations (DPBS  +) for 30 rain and then rinsed with fresh 
DPBS +. Where indicated, cells were permeabilized with 0.4% Triton X-100 
in DPBS-. Intact or permeabilized cells were incubated with 25 p.g/ml goat 
1213 anti-human fibronectin that was affinity purified and characterized  as 
described (62)  in  1 mg/ml BSA  followed by  1:100 FITC-labeled rabbit 
anti-goat IgG (Miles Scientific  Div.).  The mounting medium contained 
1 mg/ml p-phenylenediamine in 10% DPBS  +, 90% glycerol to inhibit pho- 
tobleaching (36).  For comparative immunolocalization of fibronectin and 
its receptor on the same cell, fibronectin receptor was localized  with 25 
/zg/ml rabbit anti-human fibronectin receptor lgG followed by rhodamine- 
labeled goat anti-rabbit lgG which had been previously depleted of reactiv- 
ity to rat IgG by passage through an 0.5 x  7-cm column of nonimmune rat 
IgG-Sepharose. Fibronectin was visualized  with a  1:100 dilution of goat 
anti-human fibronectin IgG directly labeled with FITC. 
lmmunofluorescence microscopy  was  performed using a  Photomicro- 
scope III (Carl Zeiss, Inc.) equipped for epifluorescence  using 40x  (NA 
1) and 63 x  (NA 1.4) objectives.  Photographs were taken with Tri-X pan 
film with speed increased to ASA  1600  using Diafine  (Accufine,  Inc., 
Chicago,  IL) and printed under conditions of identical exposure and devel- 
opment to permit direct comparisons. Antibody binding to extracellular 
fibronectin was quantified by photometry as described previously (16) using 
a 25 x  objective and the Photomicroscope III photometer set to measure the 
entire field at 800 ASA. 
Alternatively,  total quantities of fibronectin in monolayers (including in- 
tracellular  pools)  were  determined  by  dot  immunoblotting.  Antibody- 
treated and control cultures were rinsed twice with DPBS + and once with 
DPBS-,  scraped with a  rubber policeman into 100 p.l 2%  SDS,  2  mM 
PMSF in 10 mM sodium phosphate, pH 7, and then incubated at 100*C for 
3 rain. Aliquots of homogenate (3 ~1) were spotted onto nitrocellulose and 
quantitatively  assayed for fibronectin as described (5), except that 5% non- 
fat milk solids were substituted  for the BSA for initial blocking, and rabbit 
anti-human plasma fibronectin  antiserum in 5% milk solids followed by 0.5 
#Ci/ml 125I-labeled protein A in 5% BSA (8.5 #Ci//~g; New England Nu- 
clear, Boston, MA) were used.  Quantities of fibronectin were calculated 
based on standards of purified human plasma fibronectin.  Because only low 
final concentrations of fibronectin were secreted and because of the risk of 
antibody cross-reaction with bovine fibronectin, secretion or release of fibro- 
nectin into medium was determined after labeling for 24 h with 10/~Ci/ml 
[35S]methionine (Translabel; ICN Biomedicals,  Inc., Irvine, CA) in 0.4 ml 
regular medium/weU  in 8-well chambers.  Medium from each well  was 
precipitated with 10% TCA, neutralized, and analyzed by SDS-PAGE, auto- 
radiography, and densitometry.  Radioactively  labeled cell monolayers were 
also subjected  to SDS-PAGE and autoradingraphy  and ~vealed no differ- 
ences in overall incorporation or in protein band patterns. 
Other Procedures 
Immunoprecipitations were carded out essentially as described (51). After 
centrifuging and preclearing, the cell extracts  were diluted  with an equal 
volume of DPBS  +  supplemented with 2.5  mg/ml crystalline BSA.  Im- 
munoprecipitations  with  the  rat  mAbs  were  performed  with  protein 
G-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ) instead of pro- 
tein A-Sepharose. mAb 13 was used at a final concentration of 20 ttg/ml, 
and mAb 16 was used at a final concentration of 50 #g/ml. 
SDS-PAGE was performed as described by Laemmli (39),  using a 4% 
stacking gel and 7.5% resolving gel. Radioactive polypeptides were visual- 
ized as described (2).  Nitrocellulose transfers  and Western blotting were 
performed  essentially as  described  (12,  15)  with  the  following  minor 
modifications.  Nonfat milk solids (5%  [wt/vol])  were  substituted  for the 
BSA for initial blocking.  Blots were then incubated with either 10 ~g,/ml 
ofmAb 13 or 50 pg/ml mAb 16 in 5% milk solids followed by 0.5 #Ci/ml 
=251-anti-rat IgG (8/zCi/#g, Amersbam Corp., Arlington Heights,  IL) in 
5% BSA. 
Staining of cells for F-actin using rhodamine-labeled  phalloidin (Molecu- 
lar Probes, Inc., Junction City, OR) was performed as described (8). Char- 
acterization of adhesive contacts on the ventral cell surface by interference 
reflection  microscopy  was performed as described (15). 
Results 
Specific Inhibition of Cell Attachment by mAb 13 
and mAb 16 
Human  fibronectin  receptor  (VLA  5)  was  purified  from 
placenta by affinity chromatography  and used to immunize 
rats for the production  of mAbs. We previously used such 
preparations to produce monospecific polyclonal anti-fibro- 
nectin receptor antibodies  (51). In the present study, two rat 
mAbs have been identified that specifically  inhibit WI38 hu- 
man lung fibroblast attachment to fibronectin.  Both mAbs 
were found to be of the IgG2, subtype by Ouchterlony mAb 
typing. As shown in Fig. 1, the WI38 fibroblasts could attach 
to substrates prepared with purified fibronectin, laminin, and 
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Figure 1. Effect of mAbs on WI38 fibroblast attachment to fibronec- 
tin, laminin, and vitronectin. Substrates were prepared by coating 
96-well tissue culture clusters with 25/zg/ml of fibronectin (A), 25 
/zg/ml of laminin (B),  or 40/zg/ml vitronectin (C).  WI38 fibro- 
blasts were either added alone (open bars) or in the presence of 
mAb  13  (stippled bars)  or  mAb  16 (crosshatched  bars).  Back- 
ground levels of cell attachment in the absence of adhesive protein 
coating are also indicated (solid bars). In A, the concentrations of 
mAbs 13 and 16 were 50/~g/ml and 2  mg/ml, respectively. In re- 
peated experiments using lower concentrations of mAb  16, an in- 
hibitory etfect,  often  only  partial,  was  still  observed.  In  B,  the 
concentrations of mAbs 13 and 16 were 2/zg/ml and 1 mg/ml, re- 
spectively. In C, the concentrations of mAbs 13 and 16 were both 
1 mg/ml. Each bar is the average of values determined from tripli- 
cate wells (+SEM). 
Akiyama et al. Fibronectin Receptor Function  865 Figure 2.  Recognition  of fibronectin  receptor  polypeptides  by 
mAbs. Immunoprecipitation of fibronectin receptor polypeptides 
from cell lysates metabolically labeled with [35S]methionine  using 
mAbs 13 (lane A) and 16 (lane B). In lane C, cell lysate was treated 
with protein G-Sepharose in the absence of mAb as a control. The 
positions of the alpha, beta, and pre-beta polypeptides are shown 
on the left, and molecular mass standards are shown on the right. 
vitronectin (Fig. 1, A-C, respectively), mAb 13 significantly 
inhibited cell attachment to both fibronectin (p <  0.001) and 
laminin (19 < 0.001). The inhibition of attachment to laminin 
occurred at low concentrations ofmAb 13; e.g., complete in- 
hibition was found at only 2/~g/ml (Fig.  1 B). These results 
are consistent with mAb 13 recognition of the integrin beta 
subunits shared by fibronectin and laminin receptors. 
As also shown in Fig. 1, rnAb 16 inhibited cell attachment 
on fibronectin substrates (p < 0.005), but had no significant 
effect on cell attachment to laminin (p > 0.98). Neither mAb 
13 (p >  0.6) nor 16 (p >  0.3) significantly inhibited cell at- 
tachment on vitronectin substrates (Fig.  1 C). These results 
are consistent with mAb 16 recognition of the specific alpha 
subunit of the receptor. The >180% inhibition of cell attach- 
ment to fibronectin by mAb 13 shown in Fig.  1 is maximal. 
In repeated experiments in which the concentration of mAb 
13 was varied over a range of 0.1-2/zg/ml, the inhibition of 
cell  attachment  consistently  became  maximal  at  m10-50 
/~g/ml IgG (not shown). 
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Figure 3. Effect of mAbs on WI38 fibroblast spreading on fibronec- 
tin, laminin, and vitronectin. Substrates were prepared by coating 
96-well tissue culture clusters with 5 #g/ml of fibronectin (A), lami- 
nin (B), or vitronectin (C).  WI38 fibroblasts were either added 
alone (open bars) or in the presence of mAb 13 (stippled bars) or 
mAb 16 (crosshatched bars). In all experiments, there was no cell 
spreading if the substrate was not coated with an adhesive protein. 
In A, the concentrations of mAbs 13 and 16 were both 500 #g/ml. 
In B, the concentrations ofmAbs 13 and 16 were 1/~g/ml and 1 mg/ 
ml, respectively. In C, the concentrations of mAbs 13 and 16 were 
both 1 mg/ml. Each bar is the average of five determinations from 
random felds of  cells (:t:SEM). In control experiments, higher con- 
centrations (up to 1 mg/ml) of mAbs 13 and 16 had no additional 
inhibitory effects on cell spreading on fibronectin substrates. 
Immunoprecipitation of  Fibronectin  Receptor 
Polypeptides with mAbs 13 and 16 
mAb 13 inununoprecipitated three radioactive polypeptides 
from lysates of  cells that had been metabolically labeled with 
[35S]methionine  (Fig.  2,  lane A).  These polypeptides have 
been identified as the alpha, beta, and pre-beta polypeptides 
of the fibronectin receptor (2,  10, 34). As shown in Fig. 2, 
lane B, mAb 16 inununoprecipitated only the alpha and ma- 
ture beta polypeptides and not the pre-beta polypeptide. Im- 
munoblots showed binding of mAb  13 only to beta and not 
alpha subunits from placenta or fibroblasts, whereas mAb 16 
could not be characterized due to drastic losses of epitope 
recognition, presumably because of the SDS denaturation. 
As in previous integrin characterizations (2,  10, 31; Fig. 2, 
lane A), the alpha polypeptide appears in the inununoprecip- 
irate because it is bound to the beta subunit. Conversely, in 
Fig. 2, lane B, the beta polypeptide is present because it is 
bound to the alpha polypeptide. The pre-beta polypeptide 
does not appear in Fig. 2, lane B, because under normal cir- 
cumstances it does not form a complex with the alpha poly- 
peptide (2). 
Inhibition of Cell Spreading by mAbs 13 and 16 
WI38 fibroblasts spread on substrates prepared with fibro- 
nectin, laminin, and vitronectin (Fig. 3, A-C, respectively). 
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spreading on both fibronectin (p <  0.001) and laminin (p < 
0.001). In contrast, mAb 16 had no significant inhibitory ac- 
tivity on fibronectin (p >  0.7),  as well as on laminin (p > 
0.25), at this standard assay termination time. As shown in 
Fig. 4, a time course analysis indicated that cell spreading 
on fibroneetin was in fact inhibited substantially for 30 min, 
but that the cells were subsequently able to overcome the in- 
hibition and were fully spread by the 60-min endpoint. This 
result can be explained by hypothesizing that the cells are 
eventually able to overcome the inhibitory effects of mAb 16 
in this  assay  system by using  a  second  adhesion  receptor 
system. 
As was the case for cell attachment, neither mAb 13 (p > 
0.97) nor 16 (p > 0.90) inhibited cell spreading on vitronec- 
tin (Fig. 3 C). The inhibitory effect ofmAb 13 on cell spread- 
ing on fibronectin was substantial but never entirely com- 
plete. In repeated experiments in which the concentration of 
mAb 13 was varied over a range of 10 #g/ml to 2 mg/ml, the 
inhibition of cell spreading consistently became maximal at 
,0200-500  #g/ml IgG (not shown).  However, even at con- 
centrations of 2  mg/ml,  the small amount of residual cell 
spreading could never be decreased to background levels. 
Similarly, when higher concentrations of mAb 16 were used 
(up to 1 mg/ml), no inhibitory effect was observed on fibro- 
nectin substrates (not shown). 
The lack of effects of both mAb 13 and 16 on cell spreading 
and attachment on vitronectin indicates that these antibodies 
are specific for class  1 integrins and do not recognize the 
class 3 vitronectin receptor. 
Promotion of Cell Spreading by mAbs 13 and 16 
Both mAb 13 and 16 could themselves serve as substrates for 
cell spreading. As shown in Fig. 5, the WI38 cells spread on 
substrates prepared with mAbs 13 and 16 in a concentration- 
dependent manner. Half-maximal spreading occurred at sim- 
ilar IgG concentrations for both mAbs (,070 #g/ml for mAb 
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IgG  (~g/ml) 
Figure 5.  Spreading of WI38 fibroblasts on mAb substrates. Sub- 
strates were prepared by coating 96-well tissue culture clusters with 
the indicated concentrations ofmAb 13 (e) or 16 (zx). The percent- 
age ofWI38 fibroblasts scored as spread at each mAb concentration 
is indicated. Each point is the average of five determinations from 
random fields of cells (+SEM). 
13 and 80/zg/ml for mAb 16). At higher antibody concentra- 
tions, the maximum level of cell spreading activity exhibited 
by both antibodies was not significantly different (p > 0.80). 
The experiment shown in Fig.  5  further demonstrates that 
neither mAb 13 nor  16 is cytotoxic. 
Effects on Cell Migration of mAbs 13 and 16 
The roles of the fibronectin receptor, or of integrin class  1 
beta receptors in general,  in fibroblast migration were ex- 
plored using mAbs 13 and 16. As quantitated in Fig. 6, WI38 
fibroblasts migrated outward readily from agarose droplets 
onto a fibronectin substrate. This migration was inhibited by 
mAb 13.  The inhibition observed with mAb 13 was highly 
significant (p < 0.0001). In contrast, no significant inhibition 
of outgrowth was observed after treatment with either mAb 
16 (p >~ 0.3) or nonimmune IgG (p >~ 0.4).  In other experi- 
ments, mAb 16 was confirmed to be noninhibitory at concen- 
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Figure 4. Time course  of WI38 fibroblast spreading  on fibronectin. 
Substrates  were prepared by coating 96-well tissue clusters  with 
5 #g/ml fibronectin. WI38 fibroblasts were either added alone (o) 
or in the presence  of 500 #g/ml mAb 13  (e), mAb 16 (A),  or 
nonimmune  rat  IgG (zx). At the  indicated  times,  the  cells  were 
fixed and scored for spreading. Each point is the average of five de- 
terminations  from random fields of cells (-t-SEM). 
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Figure 6. Effects of anti-receptor 
mAbs on WI38 fibroblast migra- 
tion.  WI38  fibroblasts  were  al- 
lowed to migrate from high density 
explants on fibronectin substrates 
as described under Materials and 
Methods. Outgrowth was quanti- 
tated by staining the explants with 
crystal violet and measuring  the 
area covered by cells, subtracting 
the area at zero time. Cells were 
either  added  to fibronectin  sub- 
strates alone (open bar) or in the 
presence  of 100 #g/ml mAb  13 
(stippled bar) or 16 (crosshatched 
bar). There was no inhibition by 
treatment  of adjacent wells with 
equal amounts of nonimmune rat 
IgG (9.35 +  0.72 mm2). 
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on Migration of W138 Fibroblasts 
Rate  n  Significance* 
#m/h  p 
Control WI38 cells  16.0  +  1.0  132  - 
WI38 cells  +  mAb  13  12.1  +  1.3  74  0.01 
WI38 cells  +  mAb  16  25.7  +  2.0  65  <0.001 
WI38 cells  +  Fab  16  24.4  5:2.5  42  <0.001 
The migration of individual cells was recorded by time-lapse video microsco- 
py, and the rates of cell migration in the presence or absence of mAbs or Fab 
fragments of mAb  16 (Fab 16) were measured as described under Materials 
and  Methods.  mAbs  13  and  16 were at 200 #g/ml and  Fab  16 was at 500 
#g/ml.  In this experiment, 500 #g/ml mAb 13 produced only slightly more in- 
hibition of migration than at 200 #g/ml (rate  =  I 1.5  +  2. I, n  =  40).  The 
values are expressed as mean +  SEM. 
* Evaluation of statistical significance of difference from control using t test. 
trations ranging from 20 to 500 #g/ml (not shown). A possi- 
ble explanation for the lack of inhibition by mAb 16 was that 
these WI38 fibroblasts were able to migrate on collagen thai 
they had secreted and which had bound to the fibronectin 
substrate:  for example, a  requirement for both fibronectin 
and collagen receptors for cell adhesion has been proposed 
for HT1080 fibrosarcoma cells by Wayner et al. (61). How- 
ever,  continuous  treatment  with  100  #g/ml  collagenase 
added to the cultures had no effects on outward migration in 
the presence or absence of mAb  16 (not shown). 
Stimulation of Single Cell Migration of mAb 16 
The effects of  the mAbs on cell migration were examined fur- 
ther by video time-lapse microscopy of single cell migration 
in sparse cultures, mAb 13 was moderately inhibitory (Table 
I). In extensive analyses, no inhibition by mAb 16 could be 
demonstrated by this independent method. Unexpectedly, a 
stimulation of migration rates was observed in the presence 
of mAb 16 (Fig. 7) that averaged 60% and was significant 
statistically (Table I). The increased rate of migration was 
not due to microaggregation of  cell surface fibronectin recep- 
tor by bivalent mAb.  As shown in Fig.  7  C and Table  I, 
monovalent Fab fragments of mAb  16 also stimulated the 
motility of individual fibroblasts in this assay. 
A  B  C 
Control  Anti-FN  Receptor ~  Fab of Anti-FN  Receptor a 
Figure Z  Effect  of mAb  16 on the motility  of individual  W138 
fibroblasts in sparse culture. Migrating WI38 fibroblasts were fol- 
lowed by video microscopy for a 15-h period. Tracings of the paths 
of five randomly selected ceils in a control culture (A) and in the 
presence of intact mAb 16 (200/~g/ml; B) and monovalent Fab frag- 
ments of mAb  16 (500 #g/ml;  C) arc shown. The tracings were 
aligned in parallel for this figure for clarity; no overall direction of 
the migration paths of these cells was noted.  Bar,  50 #m. 
Inhibition of  Extracellular Matrix Assembly by mAb 16 
Besides possible roles in adhesion and migration, obvious 
potential functions of fibronectin receptors could be in the 
retention and organization of secreted fibronectin into fibrils. 
Effects of the anti-fibronectin alpha subunit antibody on this 
matrix assembly process were examined by immunofluores- 
cence and radiolabeling approaches. In Fig. 8, immunofluo- 
rescence  microscopy for  fibronectin shows  that  mAb  16 
treatment resulted in a  substantial decrease in fibronectin 
fbril accumulation.  There were striking decreases in the 
numbers and thickness of fibronectin fibrils (Fig. 8 Cand D). 
Similar inhibition was observed after treatment with mono- 
valent Fab fragments of mAb 16 (Fig. 8 E). After permea- 
bilization of cells, intracellular pools of fibronectin became 
visible, which appeared similar to those of control cells (Fig. 
9).  No  additional fibronectin fibrils were visualized after 
permeabilization. In addition, a subpopulation of cells dis- 
played unusual, dot-like strings or aggregates of fibronectin 
accumulating on the substrate under the ventral cell surface 
(e.g., Fig. 9 D). These structures were most frequent under 
cells with a free edge not in contact with other cells; '~20% 
of the cells displayed such clustered spots (22  +  5 %, count- 
ing 600 cells).  A  similar striking inhibition of fibronectin 
fibril formation was found with mAb 13 treatment (Fig. 9 
C). With mAb 13, 21  +  3 % of the cells showed clusters of 
ventral dots of fibronectin. These clusters appeared to be 
present in larger numbers per cell. 
The effects ofmAb 16 on levels of  extracellular fibronectin 
were concentration dependent,  as  shown quantitatively in 
Fig. 10. There was significant inhibition when even 1/~g/ml 
of the antibody was used (<40% inhibition, p <  0.001), in- 
creasing gradually to a level of 85 % inhibition at 200 #g/ml 
mAb 16. Total fibronectin in WI38 monolayers treated with 
mAb 16 was also quantitated by dot immunoblotting. These 
measurements included both extracellular and biosynthetic 
intracellular pools of fibronectin. As shown in the legend to 
Fig.  11, there were also substantially decreased amounts of 
fibronectin in mAb 16-treated cultures by this criterion as 
well. 
Fibronectin released  into culture medium from control 
and mAb 16-treated cultures was evaluated directly by elec- 
trophoretic analysis of radiolabeled cultures. The decreased 
levels of fibronectin in the cell monolayers described above 
were accompanied by a corresponding increase of approxi- 
mately fourfold the fibronectin released into culture medium 
as shown in Fig. 11. These results all suggest that the defect 
in matrix assembly was due to impaired retention on the cell 
surface and  not to  inhibition of fibronectin synthesis.  In 
repeated experiments, a clear inhibition of matrix assembly 
by mAb 16 was found in all experiments, with the inhibition 
of fibronectin accumulation varying from 60  to  85%  in 
different experiments. A similar substantial inhibition of  ma- 
trix assembly was observed after mAb 16 treatment of hu- 
man foreskin fibroblasts (not shown). 
We examined the distribution of fibronectin receptors after 
such mAb treatment using polyclonal, monospecific anti-fi- 
bronectin receptor antibodies characterized previously (51). 
As shown in Fig. 8 F, controls showed a characteristic orga- 
nization of integrin receptors into streaks, previously shown 
to correlate with extracellular fibronectin fibrils as well as 
with certain intracellular cytoskeletal elements (15, 16, 20). 
The Journal of Cell Biology, Volume  109, 1989  868 Figure 8. Single-antibody immunofluorescence analysis of matrix assembly by WI38 fibroblasts. WI38 fibroblasts were grown in regular 
medium alone (A) or in the presence of 200 #g/ml control IgG (B), 50/zg/ml mAb 16 (C), 200/~g/ml  mAb 16 (D), or 200 #g/ml Fab 
fragments of mAb 16 (E). The formation of fibronectin fibrils was visualized by fixing the cells and staining them with affinity-purified 
goat anti-fibronectin  antibodies  followed by FITC-conjugated rabbit anti-goat IgG antibodies.  For comparison  of receptor distribution, 
cells were stained with polyclonal rabbit anti-human fibronectin receptor after growth in regular medium either alone (F) or in the presence 
of 200/~g/ml  mAb 16 (G). Bars:  (A-E) 10 #m; (F and G) 10/~m. 
In contrast, cells treated with mAb 16 revealed a marked loss 
of this receptor clustering; instead, the receptor became rela- 
tively diffusely distributed on the cell  surface (Fig.  8  G). 
Few,  if any, streaks of receptor staining could be detected. 
However,  local  increases  in  immunofluorescence  staining 
were seen where cell margins overlapped (Fig. 8 G). In con- 
trol experiments, Fab fragments ofmAb 16 produced a simi- 
lar diffuse pattern of receptor. A similar diffuse organization 
of receptor on the cell surface was seen by direct staining of 
bound  mAb  16  anti-alpha  subunit  antibodies  themselves 
with rabbit anti-rat IgG (not shown). 
The relative distribution of fibronectin and receptors was 
examined by comparative double immunofluorescence label- 
ing of the same cells (Fig. 9).  As noted in the previous lit- 
erature,  controls  showed  a  striking,  though  not  absolute, 
concordance of staining with anti-fibronectin and anti-fibro- 
nectin receptor antibodies. After mAb 16 treatment, the dis- 
tribution became diffuse, and no clustering of receptor could 
be detected even over the mAb 16-induced spots of fibronec- 
tin found under the ventral surfaces of certain cells (Fig. 9). 
Thus, treatment with mAb 16 resulted in receptor redistribu- 
tion as well as in a substantial inhibition of fibronectin reten- 
Akiyama et al. Fibronectin  Receptor Function  869 Figure 9. Redistribution of  fibrone£tin receptor after treatment with mAbs and comparison by double-antibody immunofluorescence analysis 
with fibronectin matrix assembly by WI38 fibroblasts. WI38 fibroblasts were grown in regular culture medium with control nonimmune 
IgG at 200 #g/ml (A and B) or in the presence of 200 #g/ml mAb 13 IgG (C) or 200 #g/ml mAb 16 (D). The localization of the fibronectin 
receptor (A'-D') was visualized by fixing the cells and staining with rabbit polyclonal anti-receptor antibodies followed by rhodamine- 
conjugated goat anti-rabbit lgG antibodies unable to bind rat lgG. Fibronectin (A-D) was visualized in the same cells by incubating with 
FITCJabeled goat anti-fibronectin  antibodies along with the goat anti-rabbit IgG. Bar, 10 #m. 
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Figure 10.  Quantitation of matrix  formation by W138 fibroblasts. 
Cultures of WI38 fibroblasts were treated with the indicated con- 
centrations  of mAb  16  or  nonimmune  IgG.  The  formation  of 
fibronectin fibrils was visualized by fixing the cells and  staining 
with affinity-purified goat anti-human fibronectin antibodies  fo]- 
tion and matrix assembly, whereas neither cell spreading nor 
migration of these normal human fibroblasts on fibronectin 
were inhibited. 
Effects of mAb 16 on Cytoskeletal Organization 
and Adhesions 
Since microfilament bundles often show partial colocaliza- 
tion with fibronectin fibrils, we examined for effects of mAb 
16 treatment on actin-containing microfilaments. As shown 
in Fig.  12, A and C, control cells showed strong rhodamine- 
phalloidin staining of F-actin in thick microfilament bundles 
(stress fibers) that often extended most of the length of cells. 
Cells treated  for 24 h  with mAb  16 appeared to have sig- 
nificantly fewer thick bundles of F-actin containing micro- 
filaments, but numerous fine strands of microfilaments were 
still retained (Fig.  12, B and D). Similar effects were found 
with Fab fragments ofmAb 16, but not with control IgG, and 
on substrates that had been precoated with purified fibronec- 
tin  (not shown). 
lowed by FITC-conjugated rabbit anti-goat IgG antibodies.  Immu- 
nofluomscence in the presence of phenylenediamine was quantitatext 
as described in Materials and Methods. Background determined in 
the absence of the first antibody was subtracted. 
The Journal of Cell Biology, Volume 109, 1989  870 Figure  11.  Autoradiographic  analysis  of fibronectin  secreted  by 
WI38 fibroblasts in the presence of mAb 16. WI38 fibroblasts were 
grown in the presence  of 50 ,aCi/ml [35S]methionine alone (lanes 
A and E), 5 ,ag/ml mAb 16 (lanes B and F), 20 #g/ml  mAb 16 
(lanes C or G), or equal amounts of rat IgG (lanes D and H). After 
24 h, a 50-,al aliquot of conditioned culture medium was resolved 
by SDS-gel electrophoresis  and analyzed by autoradiography. The 
fibronectin  band  (arrow)  was confirmed  by immunoprecipitation 
with rabbit anti-human fibronectin antibody. Scanning densitome- 
try of  fibronectin in relative absorbance units, setting untreated con- 
trois  =  1.00, showed 5 ,ag/ml mAb 16 =  3.97; 20/~g/ml  mAb 16 
=  4.04;  and IgG control  =  1.31. Dot immunoblot quantitation of 
fibronectin  in the remaining cell  monolayers was also performed 
directly  using anti-fibronectin  and  ~2~I as described  under  Mate- 
rials and Methods; radioactivity was determined in a gamma counter 
to obtain data independent of the 35S labeling. Relative amounts of 
fibronectin,  with controls  =  1.00, were 5 ,ag/ml mAb 16 =  0.45; 
20 ,ag/ml mAb 16  =  0.34;  and control IgG =  0.78. In a separate 
experiment,  200  ,ag/ml mAb  16 did  not produce  a  significantly 
larger decrease  (32 vs. 34%  in this experiment). 
Concomitant  with  this  decreased  formation  of  thick 
microfilarnent bundles,  we observed striking alterations  in 
cell-substratum  contacts  as  characterized  by  interference 
reflection microscopy (Fig.  13, A and B).  Untreated WI38 
fibroblasts had numerous dark contact regions indicative of 
close approach to the culture substrate in adhesion plaques 
and  prominent streak-like contacts corresponding,  respec- 
tively, to specialized adhesion sites termed focal contacts and 
extracellular matrix contacts (e.g., see 15). As shown in Fig. 
13, treatment with mAb 16 resulted in decreased numbers of 
these darkest contacts, with especially striking losses of the 
streak-like extracellular matrix contacts. The ventral surface 
instead appeared as a relatively uniform series of greys, char- 
acteristic of the "close" contacts found in migrating cells (Fig. 
13 B).  Fab fragments of mAb 16 produced similar effects, 
but control nonimmune rat IgG had no detectable effects (not 
shown).  Inhibition by mAb  16 was also observed on  sub- 
strates precoated with fibronectin (not shown). 
Discussion 
We have developed two mAbs that bind to different subunits 
of the  fibronectin receptor heterodimer complex and  used 
them to dissect the function of this receptor in cell biological 
functions  in  vitro.  The  related,  but  sometimes  distinct, 
effects of these antibodies on a variety of biological assay sys- 
tems are summarized in Table II which evaluates cell adhe- 
sions, morphology, cell migration, extracellular matrix as- 
sembly, and microfilament bundle formation. 
Blocking  the  function  of the  beta  subunit  had  multiple 
effects, including inhibiting cell adhesion to both fibronectin 
and laminin but not to vitronectin. These results were antici- 
pated because a  single beta polypeptide can associate with 
one of several different alphas to form receptors for fibronec- 
tin, collagen, or laminin (25, 54-58).  In contrast, adhesion 
to vitronectin is mediated by distinct class 3 integrins (14,  17, 
27,  33,  48).  The  anti-alpha  subunit  antibody mAb  16  in- 
hibited cell attachment to fibronectin but not to laminin or 
vitronectin.  However,  it  had  no  effect  in  a  standard  cell 
spreading assay on fibronectin, laminin, or vitronectin sub- 
strates.  There was thus  a  discrepancy between attachment 
and spreading assays, which showed inhibition or no inhibi- 
Figure 12.  Alterations  in microfilament bundle organization.  WI38 fibroblasts were cultured  for 24 h in regular culture  medium in the 
presence or absence of 200 ,ag/ml mAb 16. For visualization of F-actin, cells were fixed and extracted with acetone and then stained with 
rhodamine-labeled  phalloidin  to compare control cells (A and  C) with mAb 16-treated  cells (B and D). Bar, 10 ,am. 
Akiyama et al. Fibronectin Receptor Function  871 Figure 13. Alterations in cell substratum contacts. WI38 fibroblasts were cultured for 24 h in regular culture medium alone (A) or in the 
presence of 200 #g/ml mAb 16 (B). For visualization of adhesive contacts at the ventral cell surface, cells were fixed with glutaralde- 
hyde/paraformaldehyde and examined immediately by interference reflection microscopy. Bar, 10/tm. 
tion, respectively, by mAb 16 of interactions with fibronec- 
tin. This apparent contradiction was resolved by examining 
a time course of cell spreading that showed substantial ini- 
tial inhibition of cell spreading for the period of time covered 
by the attachment assay, but then eventually showed success- 
ful  cell  spreading  by  the  time  of termination  of routine 
spreading assays.  The simplest explanation of these results 
is that attachment and early phases of spreading are depen- 
dent  on  fibronectin  receptor  function,  but  subsequent 
spreading  uses  another  as  yet undefined class  1  integrin 
receptor system. 
The alpha subunit appears to play an important role in the 
assembly of the fibronectin-containing extracellular matrix. 
Blocking  either  alpha  or  beta  subunits  inhibited  cellular 
retention of endogenous fibronectin and extracellular matrix 
formation. Instead of forming a matrix, newly synthesized 
Table II. Summary of  lnhibitory Activities of 
Anti-Fibronectin Receptor Antibodies 
Assay  Anti-alpha  mAb  16  Anti-beta mAb 13 
Cell attachment 
Fibronectin  Inhibits  Inhibits 
Laminin  No effect  Inhibits 
Vitronectin  No effect  No effect 
Cell spreading 
Fibronectin  No effect  Inhibits 
Laminin  No effect  Inhibits 
Vitronectin  No effect  No effect 
Cell migration from explant  No effect  Inhibits 
Single cell migration  Enhances  Partially inhibits 
Matrix assembly  Inhibits  Inhibits 
Actin microfilament bundles  Inhibits  Inhibits 
Focal and streak-like extracel-  Inhibits  Inhibits 
lular matrix contacts 
fibronectin was secreted into the culture medium, mAb  16 
thus appears to inhibit matrix formation by inhibiting the cell 
surface retention rather than the biosynthesis of fibronectin. 
In previous studies, two different assay systems have been 
used to analyze matrix assembly by cultured human fibro- 
blasts. In one series of studies, the incorporation of isolated, 
exogenous plasma fibronectin into the extracellular matrix 
was examined (41-43). Because this assay system was partic- 
ularly  sensitive  to  an  exogenously added  amino-terminal 
fragment of fibronectin that lacks the cell adhesive domain, 
these investigators proposed the existence of a matrix assem- 
bly fibronectin receptor that is distinct from the VLA 5 cell 
attachment fibronectin receptor (43). The matrix assembly 
assay used in the present study directly examines the incor- 
poration of endogenous fibroblast fibronectin into fibrils, an 
assay similar to that of McDonald et al. (40). The assembly 
of endogenous  fibroblast-derived  fibronectin  into  an  ex- 
tracellular matrix has been shown to require the cell adhesive 
domain of fibronectin (40). The results presented here also 
indicate that both subunits of the fibronectin adhesion recep- 
tor itself are also required for the assembly of endogenous 
fibroblast cellular fibronectin into an extracellular matrix. 
Even  after  treatment  with  high  concentrations  of  the 
mAbs,  there are some residual short fibrils or circular ag- 
gregates (dot- or spot-like patterns) of fibronectin visible on 
or under the fibroblasts. The origin of the dot-like patterns 
of fibronectin is not known. The two most likely possibilities 
are that they represent fibroblast cellular fibronectin that is 
aggregated or precipitated abnormally on the ventral (lower) 
cell surface-substrate interface after secretion, or that they 
represent natural precursors of fibronectin fibrils. 
The precise roles of the alpha and beta subunits in fibro- 
blast migration are less clear. Both the outward migration of 
human fibroblasts from cell explants and the random migra- 
tion of single cells in sparse cultures on fibronectin were in- 
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13) but not by the antibody against the alpha subunit (mAb 
16). This finding, like the lack of inhibition of cell spreading 
on fibronectin, suggests the possible existence of a second 
mechanism  of  cell-fibronectin  interaction.  This  second 
mechanism does not appear to involve collagen, since high 
levels of collagenase did not interfere with cell migration. 
Rather than inhibiting migration, the anti-alpha mAb un- 
expectedly stimulated significantly the migration of single 
cells as followed by time-lapse microscopy. This stimulation 
may be explained by our findings that mAb 16 caused a de- 
crease  in  cell-substrate adhesive contacts associated  with 
immobility (i.e., in "focal" contacts and especially in streak- 
like extracellular matrix  contacts)  and also  converted in- 
tegrin receptor patterns from a  clustered to a diffuse dis- 
tribution.  Previous  studies  have  suggested  that  a  diffuse 
distribution of the receptor is characteristic of rapidly mi- 
grating and malignant cells (16, 21, 22, 53). The absence of 
the streak-like receptor patterns associated with decreases in 
ventral cell adhesions and transmembrane linkages (16) would 
permit accelerated cell migration. 
In a previous report, it was suggested that the interaction 
of fibronectin fibrils with cells regulates the distribution of 
the fibronectin receptor (16). The present study suggests that 
this putative regulatory interaction can be blocked by either 
anti-alpha or -beta subunit antibodies. 
The disruption of receptor clustering on human fibroblasts 
is reminiscent of similar effects on avian integrin receptor 
clustering by an mAb against the shared class 1 beta subunits 
of avian cells. Duband et al. (22) observed that treatment of 
avian ceils  with  a  wide-spectrum anti-integrin mAb  also 
resulted in a more diffuse receptor distribution and high mo- 
bility of that  receptor.  In the present study,  however, the 
diffuse pattern could be induced even by antibodies that bind 
only to the alpha subunit of a single integrin receptor, point- 
ing to VLA 5 as the crucial integrin in these redistribution 
effects. 
Previous studies (18, 22) described correlations between 
the slowing of cell migration, formation of adhesive contacts 
with clusters of integrin receptors, organization of the actin 
microfilament cytoskeleton, and increased accumulation of 
a fibronectin matrix. It is noteworthy that mAb 16 generally 
produces the opposite effects. The broader-specificity mAb 
13 also interferes with two other processes, cell spreading 
and  migration,  presumably because  it also  inhibits  other 
integrins including VLA 2 and VLA 3 (e.g., see 57, 60, 61). 
Fig.  14 is a summary of the findings from this and other 
papers suggesting how the fibronectin receptor m~iates its 
effects on cell behavior and morphology. If the streak-like 
clusters of receptor on the dorsal  (upper) cell surface are 
functionally equivalent to the receptor clusters at adhesive 
sites  on the ventral cell surface,  the key element in both 
these adhesive structures and in matrix assembly would be 
the presence of multivalent clusters of fibronectin receptor 
that  bind  to  fibrils  of fibronectin.  We  suggest  that  mul- 
tivalency then results in high net affinity (e.g., see Discus- 
sion in 22), which holds cells more effectively in place and 
thus slows cell migration if located on the ventral surface. 
Alternatively, multivalent receptor clusters located on the 
dorsal  surface  contribute  to  the  assembly  of fibronectin 
fibrils. Thus, clustered fibronectin receptors may play a cen- 
tral role in establishing the stationary cell phenotype-e.g., 
when certain embryonic cells cease migration and establish 
a surrounding extracellular matrix. 
Treatment  of  cells  with  mAb  16  appears  to  disrupt 
fibronectin receptor clustering and function without interfer- 
ing with other cell adhesion receptors, resulting in a loss of 
fibronectin due to  poor matrix  assembly  and  accelerated 
migration due to lack of certain ventral adhesions. However, 
there are only transient effects on cell adhesion that can be 
rapidly overcome by other adhesive mechanisms that permit 
cell spreading and migration.  In addition, actin microfila- 
ment bundle organization is partially inhibited, probably due 
to the disruption of transmembrane linkages with fibronectin 
fibrils. In conclusion, receptor clustering, fibronectin fibril 
formation, microfilament bundle formation, firm adhesion, 
and migration are apparently interdependent processes regu- 
lated by the state of this single cell surface receptor. 
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Figure 14. Diagrammatic summary of key find- 
ings of this study. Black squares represent the 
VLA-5 fibronectin receptor associated with in- 
tracellular microfilament bundles. The thicker 
strands on the cell surface represent fibronectin 
fibrils and  the  thinner  wavy lines  represent 
secreted  fibronectin.  Untreated  WI38  fibro- 
blasts  (top)  are  compared  with cells  treated 
with mAb 16 directed against the alpha subunit 
of the fibronectin receptor (bottom left) or with 
mAb 13 against the beta subunit. See text for 
discussion. 
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